Quality of life outcomes after deep brain stimulation in dystonia: A systematic review.

Abstract:

:Dystonia is an incurable movement disorder which can cause not only physical but also mental problems, leading to impaired health-related quality of life (HRQoL). For patients with dystonia refractory to medical treatment, deep brain stimulation (DBS) is a well-established surgical treatment. The objective of this systematic review is to provide a better understanding of HRQoL outcomes after DBS for dystonia. A search of the literature was conducted using Medline (PubMed), Embase, and Cochrane Library databases in May 2019. HRQoL outcomes after DBS along with motor outcomes were reported in a total of 36 articles involving 610 patients: 21 articles on inherited or idiopathic isolated dystonia, 5 on tardive dystonia, 3 on cerebral palsy, 2 on myoclonus-dystonia, 1 on X-linked dystonia-parkinsonism, and 3 on mixed cohorts of different dystonia subtypes. DBS improved motor symptoms in various subtypes of dystonia. Most studies on patients with inherited or idiopathic isolated dystonia showed significant improvement in physical QoL, whereas gains in mental QoL were less robust and likely related to the complexity of associated neuropsychiatric problems. HRQoL outcomes beyond 5 years remain scarce. Although the studies on patients with other subtypes of dystonia also demonstrated improvement in HRQoL after DBS, the interpretation is difficult because of a limited number of articles with small cohorts. Most articles employed generic measures (e.g. Short Form Health Survey-36) and this highlights the critical need to develop and to utilize sensitive and disease-specific HRQoL measures. Finally, long-term HRQoL outcomes and predictors of HRQoL should also be clarified.

authors

Tsuboi T,Wong JK,Okun MS,Ramirez-Zamora A

doi

10.1016/j.parkreldis.2019.11.016

subject

Has Abstract

pub_date

2020-01-01 00:00:00

pages

82-93

eissn

1353-8020

issn

1873-5126

pii

S1353-8020(19)30492-4

journal_volume

70

pub_type

杂志文章
  • Genetic causes of Parkinson's disease and their links to autophagy regulation.

    abstract::Genetic studies over the past 15 years have revolutionized our understanding towards the etiology of Parkinson's disease (PD). These studies have discovered many disease-linked genetic loci (PARK 1 to 18), which are now being interrogated for cellular pathways contributing to PD. Various pathogenic pathways were propo...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/S1353-8020(13)70037-3

    authors: Pan PY,Yue Z

    更新日期:2014-01-01 00:00:00

  • Glutamatergic inputs to midbrain dopaminergic neurons in primates.

    abstract::Anterograde tract-tracing and immunohistochemical methods were used to study projections from the pedunculopontine tegmental nucleus (PPN) to midbrain dopaminergic neurons in the squirrel monkey (Saimiri sciureus). The PPN harbored numerous cholinergic and glutamatergic neurons, as well as neurons that displayed both ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/s1353-8020(99)00037-1

    authors: Parent A,Parent M,Charara A

    更新日期:1999-12-01 00:00:00

  • Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia.

    abstract::The goal of genetic association studies is to identify common (>5%) risk factors in complex disease traits. Herein we describe the first replicable 'functional' risk allele for Parkinson's disease. The leucine-rich repeat kinase 2 (Lrrk2) G2385R substitution is associated with familial parkinsonism, late-, and early-o...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2006.12.001

    authors: Farrer MJ,Stone JT,Lin CH,Dächsel JC,Hulihan MM,Haugarvoll K,Ross OA,Wu RM

    更新日期:2007-03-01 00:00:00

  • Treatment of depression in Parkinson's disease with moclobemide: A pilot open-label study.

    abstract::Moclobemide, a potent reversible monoamine-oxidase A (MAO-A) inhibitor, is an effective antidepressant that does not cause impairment of cognitive function in elderly patients and might be beneficial to motor deficits in Parkinson's disease (PD). In a 12-week open-label prospective study, we administered moclobemide (...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/s1353-8020(97)00028-x

    authors: Giménez-Roldán S,Dobato JL,Mateo D

    更新日期:1997-12-01 00:00:00

  • Effects of optimism/pessimism and locus of control on disability and quality of life in Parkinson's disease.

    abstract:PURPOSE:To assess optimism/pessimism and locus of control in a sample of Parkinson's disease patients and to evaluate their impact on disability and health-related quality of life. METHODS:99 patients with Parkinson's disease completed the Life Orientation Test, Multidimensional Health Locus of Control, Older American...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2009.03.005

    authors: Gruber-Baldini AL,Ye J,Anderson KE,Shulman LM

    更新日期:2009-11-01 00:00:00

  • Limb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training.

    abstract::Recent evidence in animal models of Parkinson's disease (PD) suggests that exercise and other forms of motor enhancement can be beneficial when applied during the degeneration of dopamine neurons. Behaviours that depend on adequate levels of striatal dopamine may provide particularly favourable targets for therapeutic...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2008.04.027

    authors: Ciucci MR,Ma ST,Kane JR,Ahrens AM,Schallert T

    更新日期:2008-01-01 00:00:00

  • Familial cortical tremor with epilepsy.

    abstract::We report here on a Japanese family in which five members in three generations developed non-progressive adult onset cortical tremor and epilepsy. Other than tremulous movements resembling essential tremor, the neurologic findings were unremarkable. Electrophysiologic studies revealed giant somatosensory evoked potent...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/s1353-8020(97)00001-1

    authors: Okuma Y,Shimo Y,Hatori K,Hattori T,Tanaka S,Mizuno Y

    更新日期:1997-04-01 00:00:00

  • Treatment of acute Sydenham's chorea with methyl-prednisolone pulse-therapy.

    abstract::Serious adverse effects with antichoreic drugs can occur in patients with acute Sydenham's chorea (SC). The response to conventional treatment in severe SC may also be poor. Thus alternative therapeutic strategies have been developed. We report on four patients with severe acute SC (two with chorea paralytica and two ...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2005.02.007

    authors: Teixeira AL Jr,Maia DP,Cardoso F

    更新日期:2005-08-01 00:00:00

  • Diagnostic accuracy of [99mTc]TRODAT-1 SPECT imaging in early Parkinson's disease.

    abstract::We evaluated the diagnostic accuracy of SPECT imaging using [(99m)Tc]TRODAT-1 (TRODAT), a relatively inexpensive technetium-labeled dopamine transporter ligand, in distinguishing 29 patients with early PD from 38 healthy volunteers. Mean TRODAT uptake values were significantly decreased in the caudate (p=0.0097) and a...

    journal_title:Parkinsonism & related disorders

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.parkreldis.2004.04.002

    authors: Chou KL,Hurtig HI,Stern MB,Colcher A,Ravina B,Newberg A,Mozley PD,Siderowf A

    更新日期:2004-08-01 00:00:00

  • Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson's disease: A systematic review and meta-analysis.

    abstract:INTRODUCTION:Neurotrophic factors (NTFs) have been evaluated for neuroprotective effects in Parkinson's disease (PD). However, clinical trials examining the efficacy of intracerebral administration of NTFs on motor symptoms in PD have produced mixed results, and are thus inconclusive. The objective of this systematic r...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.parkreldis.2017.02.011

    authors: Hegarty SV,Lee DJ,O'Keeffe GW,Sullivan AM

    更新日期:2017-05-01 00:00:00

  • Quality of sleep in young onset Parkinson's disease: Any difference from older onset Parkinson's disease.

    abstract:BACKGROUND:Sleep disorders occur commonly in Parkinson's disease and are often under-recognized and under treated in clinical practice. OBJECTIVES:To determine the quality of sleep in patients with Young onset Parkinson's disease (YOPD) and to note whether there is any difference in quality of sleep from those patient...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2015.02.007

    authors: Mahale R,Yadav R,Pal PK

    更新日期:2015-05-01 00:00:00

  • Resting activity in visual and corticostriatal pathways in Parkinson's disease with hallucinations.

    abstract:BACKGROUND:Visual hallucinations are an important non-motor complication of Parkinson's disease (PD) and carry a negative prognosis. Their biological basis is uncertain, but may relate to the activity of resting state networks in brain. We therefore aimed to investigate functional activity of brain in patients with vis...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2014.11.020

    authors: Yao N,Pang S,Cheung C,Chang RS,Lau KK,Suckling J,Yu K,Mak HK,McAlonan G,Ho SL,Chua SE

    更新日期:2015-02-01 00:00:00

  • Glucocerebrosidase mutations in diffuse Lewy body disease.

    abstract::Clinicogenetic and pathological studies have shown that mutations of the glucocerebrosidase gene (GBA) are a risk factor for Parkinson's disease and Lewy body disorders. In the present study, we have identified GBA mutations in 6.8% (4/59) of cases with a pathological diagnosis of diffuse Lewy body disease. Taken with...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2010.09.009

    authors: Nishioka K,Ross OA,Vilariño-Güell C,Cobb SA,Kachergus JM,Mann DM,Snowden J,Richardson AM,Neary D,Robinson CA,Rajput A,Papapetropoulos S,Mash DC,Pahwa R,Lyons KE,Wszolek ZK,Dickson DW,Farrer MJ

    更新日期:2011-01-01 00:00:00

  • Benign hereditary chorea: an update.

    abstract::Benign hereditary chorea (BHC, MIM 118700) is a rare autosomal dominant disorder manifesting with chorea in conjunction with hypothyroidism and respiratory problems, a triad also named "brain-lung-thyroid syndrome". BHC is characterized by childhood onset with minimal or no progression into adult life and normal cogni...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2011.01.002

    authors: Inzelberg R,Weinberger M,Gak E

    更新日期:2011-06-01 00:00:00

  • Red flags phenotyping: A systematic review on clinical features in atypical parkinsonian disorders.

    abstract::To establish a clinical diagnosis of a parkinsonian disorder, physicians rely on their ability to identify relevant red flags, in addition to cardinal features, to support or refute their working diagnosis in an individual patient. The term 'red flag', was originally coined in 1989 to define the presence of non-cardin...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2018.10.009

    authors: Bhidayasiri R,Sringean J,Reich SG,Colosimo C

    更新日期:2019-02-01 00:00:00

  • Acceleration of syllable repetition in Parkinson's disease is more prominent in the left-side dominant patients.

    abstract:BACKGROUND:In Parkinson's disease (PD), abnormalities of speech rate have been observed in spontaneous speech, reading tasks and syllable repetition tasks. Impaired temporal speech patterns have been contributed to dysfunctional basal ganglia circuits, but little is known about a possible differential role of right and...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2011.11.021

    authors: Flasskamp A,Kotz SA,Schlegel U,Skodda S

    更新日期:2012-05-01 00:00:00

  • Chronic and acute LRRK2 silencing has no long-term behavioral effects, whereas wild-type and mutant LRRK2 overexpression induce motor and cognitive deficits and altered regulation of dopamine release.

    abstract:INTRODUCTION:Germline silencing of the PD-related protein LRRK2 does not alter glutamate or dopamine release in adult mice, but some exploratory abnormalities have been reported with ageing. Contrastingly, high levels of human LRRK2 cause locomotor alterations and cognitive deficits accompanied by reduced striatal dopa...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2015.07.025

    authors: Volta M,Cataldi S,Beccano-Kelly D,Munsie L,Tatarnikov I,Chou P,Bergeron S,Mitchell E,Lim R,Khinda J,Lloret A,Bennett CF,Paradiso C,Morari M,Farrer MJ,Milnerwood AJ

    更新日期:2015-10-01 00:00:00

  • Proton magnetic resonance spectroscopy of the striatum in Parkinson's disease patients with motor response fluctuations.

    abstract::We have performed proton magnetic resonance spectroscopy centred on the putamen contralateral to the worst affected side in 10 patients with idiopathic Parkinson's disease (PD) and motor response fluctuations and seven age matched healthy controls. In PD, there was striking reduction in the N-acetylaspartate (NAA) and...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/1353-8020(96)00007-7

    authors: Chaudhuri KR,Lemmens GM,Williams SC,Ellis C,Lloyd CM,Dawson J,Simmons A,Leigh PN

    更新日期:1996-04-01 00:00:00

  • Diagnostic delay in Parkinson's disease caused by PRKN mutations.

    abstract:OBJECTIVE:To confirm that there is a diagnostic delay in Parkin-related Parkinson Disease and to explore possible factors causing such a delay. METHODS:We retrospectively analyzed our patients with mutations in the parkin RBR E3 ubiquitin protein ligase gene (PRKN). We collected a total of 34 patients and focused on 1...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2019.01.010

    authors: Ruiz-Lopez M,Freitas ME,Oliveira LM,Munhoz RP,Fox SH,Rohani M,Rogaeva E,Lang AE,Fasano A

    更新日期:2019-06-01 00:00:00

  • Sensory neuropathy in autosomal recessive juvenile parkinsonism (PARK2).

    abstract::Autosomal recessive juvenile parkinsonism (ARJP/PARK2) is a distinct clinical and genetic entity characterized by early-onset levodopa-responsive parkinsonism, foot dystonia, sleep benefit, and hyperactive tendon reflexes. We report a patient with genetically confirmed ARJP, who showed mild sensory disturbance and dim...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/s1353-8020(02)00114-1

    authors: Okuma Y,Hattori N,Mizuno Y

    更新日期:2003-06-01 00:00:00

  • Does the cerebellum intervene in the abnormal somatosensory temporal discrimination in Parkinson's disease?

    abstract:INTRODUCTION:somatosensory temporal discrimination threshold (STDT) measures the ability to perceive two stimuli as being sequential. Altered STDT has been reported in Parkinson's disease (PD). The cerebellum seems to play a role in the pathophysiology of PD, and may consequently be involved in the pathophysiology of S...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2015.04.004

    authors: Di Biasio F,Conte A,Bologna M,Iezzi E,Rocchi L,Modugno N,Berardelli A

    更新日期:2015-07-01 00:00:00

  • Middle latency auditory evoked potentials in patients with parkinsonism.

    abstract::The aim of this study was to assess the middle latency auditory evoked potential (MLAEP) findings in idiopathic Parkinson's disease (IPD) and in patients who are regarded as having atypical parkinsonian disorders (AP) and to determine whether MLAEPs could contribute to the differential diagnosis of IPD and AP.MLAEPs w...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/s1353-8020(99)00056-5

    authors: Çelik M,Seleker FK,Sucu H,Forta H

    更新日期:2000-04-01 00:00:00

  • Developing a PD Service.

    abstract::Several changes to society in the last four decades have had implications for people and their families living with Parkinson's disease (PD): (1) The change in the role of voluntary organisations highlighting the importance of listening to the needs of the patients and their families. (2) Demographic changes resulting...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/S1353-8020(08)70056-7

    authors: Baker MG

    更新日期:2007-01-01 00:00:00

  • Memory perception and strategy use in Parkinson's disease.

    abstract::Although there is growing support for the existence of memory deficits within Parkinson's disease (PD), little has been done to evaluate the extent to which PD patients demonstrate differences in their use of metacognitive strategies. In the present study, 79 PD patients (46 men and 33 women) and 49 age-matched health...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2004.06.005

    authors: Johnson AM,Pollard CC,Vernon PA,Tomes JL,Jog MS

    更新日期:2005-03-01 00:00:00

  • Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry.

    abstract:INTRODUCTION:Continuous infusion of levodopa/carbidopa intestinal gel (LCIG) is an effective treatment for patients with advanced Parkinson Disease (PD) that cannot be further improved by oral therapy. METHODS:We conducted an observational, prospective, and multicenter study to collect, in a large sample of PD treated...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.parkreldis.2015.05.014

    authors: Buongiorno M,Antonelli F,Cámara A,Puente V,de Fabregues-Nebot O,Hernandez-Vara J,Calopa M,Pascual-Sedano B,Campolongo A,Valldeoriola F,Tolosa E,Kulisevsky J,Martí MJ

    更新日期:2015-08-01 00:00:00

  • Adenosine, adenosine A 2A antagonists, and Parkinson's disease.

    abstract::Adenosine derived from the degradation of ATP/AMP functions as a signalling molecule in the nervous system through the occupation of A1, A2, and A3 adenosine receptors. Adenosine A(2A) receptors have a selective localization to the basal ganglia and specifically to the indirect output pathway, and as a consequence off...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/j.parkreldis.2008.12.006

    authors: Jenner P,Mori A,Hauser R,Morelli M,Fredholm BB,Chen JF

    更新日期:2009-07-01 00:00:00

  • Neuropsychiatric aspects of treated Wilson's disease.

    abstract::The objective of the current cross-sectional study was to use standardized psychiatric interviews (the Structured Clinical Interview for DSM-IV Axis I Disorders and the Neuropsychiatric Inventory; NPI) in order to better characterize psychiatric symptoms in 50 consecutive, treated and clinically stable patients with W...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2009.01.010

    authors: Svetel M,Potrebić A,Pekmezović T,Tomić A,Kresojević N,Jesić R,Dragasević N,Kostić VS

    更新日期:2009-12-01 00:00:00

  • Olfaction in Parkinson's disease.

    abstract::It has become increasingly apparent that Parkinson's disease (PD) can no longer be considered purely a motor disease, as numerous sensory alterations accompany this disorder either before or early in its clinical progression. Most notable among such disturbances are decrements in smell function. Such anomalies have be...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/S1353-8020(08)70006-3

    authors: Doty RL

    更新日期:2007-01-01 00:00:00

  • Mouse models for LRRK2 Parkinson's disease.

    abstract::Parkinson's disease (PD) is the second most common neurodegenerative disease. Mutations in Leucine-rich-repeat-kinase 2 (LRRK2), the causative gene for PARK8 type PD with autosomal dominant inheritance, are the most prevalent genetic causes of both familial and sporadic PD. Animal models are critical tools in the atte...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章,评审

    doi:10.1016/S1353-8020(11)70058-X

    authors: Xu Q,Shenoy S,Li C

    更新日期:2012-01-01 00:00:00

  • Ischemic injury precipitates neuronal vulnerability in Parkinson's disease: Insights from PINK1 mouse model study and clinical retrospective data.

    abstract:INTRODUCTION:Increasing evidence demonstrates the relevant association between Parkinson's disease (PD) and vascular diseases/risk factors, as well as a worse clinico-pathological progression in those patients with vascular comorbidity. The mechanisms underlying this relationship have not been clarified yet, although t...

    journal_title:Parkinsonism & related disorders

    pub_type: 杂志文章

    doi:10.1016/j.parkreldis.2020.04.004

    authors: Imbriani P,D'Angelo V,Platania P,Di Lazzaro G,Scalise S,Salimei C,El Atiallah I,Colona VL,Mercuri NB,Bonsi P,Pisani A,Schirinzi T,Martella G

    更新日期:2020-05-01 00:00:00